ADVERTISEMENT
Bassil Dahiyat is president and CEO of Xencor Inc.
As the first generation of biologics patents expire, companies are jokeying for position in follow-on biologics.
How Virtual Media Can Save the Medical Speaker Program Sponsored By MedPoint Communications, Inc.Building Market Share Through Patient Segmentation Strategies: New Ideas and Best Practices to Enhance ROI Sponsored By Healthgrades Risk, Reward and the Pharmaceutical Life Cycle: Managing Information as a Strategic Productivity Asset Sponsored By IntraLinks
Disclosure of Drug Promotion Expenses: How Automated Reporting and Master Data Management Can Improve Sponsored By Cegedim ARCHIVED WEBCASTS